Literature DB >> 8945765

Adenosine A1 receptor blockade selectively potentiates the motor effects induced by dopamine D1 receptor stimulation in rodents.

P Popoli1, L Giménez-Llort, A Pezzola, R Reggio, E Martínez, K Fuxe, S Ferré.   

Abstract

An antagonistic interaction between adenosine A1 and dopamine D1 receptors has previously been found in the basal ganglia. However, direct evidence for a selective adenosine A1 antagonist-induced potentiation of dopamine D1-mediated motor activation is lacking. The systemic administration of the adenosine A1 antagonist 8-cyclopentyl-1,3-dimethylxanthine significantly potentiated the motor activating properties of the systemically administered dopamine D1 agonist SKF 38393 in both reserpinized mice and unilaterally 6-hydroxy-dopamine-lesioned rats. However, 8-cyclopentyl-1, 3-dimethylxanthine did not modify the motor effects of the dopamine D2 agonist quinpirole. The present work shows that an antagonistic interaction between adenosine A1 and dopamine D1 receptors may be involved in the motor activating effects of adenosine antagonists, like caffeine.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8945765     DOI: 10.1016/s0304-3940(96)13143-8

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  23 in total

Review 1.  Adenosine-dopamine interactions in the pathophysiology and treatment of CNS disorders.

Authors:  K Fuxe; D Marcellino; D O Borroto-Escuela; M Guescini; V Fernández-Dueñas; S Tanganelli; A Rivera; F Ciruela; L F Agnati
Journal:  CNS Neurosci Ther       Date:  2010-03-16       Impact factor: 5.243

Review 2.  Mechanisms of the psychostimulant effects of caffeine: implications for substance use disorders.

Authors:  Sergi Ferré
Journal:  Psychopharmacology (Berl)       Date:  2016-01-20       Impact factor: 4.530

3.  The effects of systemic, intrastriatal, and intrapallidal injections of caffeine and systemic injections of A2A and A1 antagonists on forepaw stepping in the unilateral 6-OHDA-lesioned rat.

Authors:  John E Kelsey; Nicole A Langelier; Brad S Oriel; Catherine Reedy
Journal:  Psychopharmacology (Berl)       Date:  2008-09-13       Impact factor: 4.530

4.  [Coffee and mental health].

Authors:  Rafael Franco
Journal:  Aten Primaria       Date:  2009-09-10       Impact factor: 1.137

Review 5.  Adenosine hypothesis of schizophrenia--opportunities for pharmacotherapy.

Authors:  Detlev Boison; Philipp Singer; Hai-Ying Shen; Joram Feldon; Benjamin K Yee
Journal:  Neuropharmacology       Date:  2011-02-17       Impact factor: 5.250

6.  Involvement of adenosine A1 and A2A receptors on guanosine-mediated anti-tremor effects in reserpinized mice.

Authors:  C M Massari; L C Constantino; N F Marques; L B Binder; M Valle-León; M López-Cano; V Fernández-Dueñas; F Ciruela; C I Tasca
Journal:  Purinergic Signal       Date:  2020-07-28       Impact factor: 3.765

7.  Dysregulation of brain adenosine is detrimental to the expression of conditioned freezing but not general Pavlovian learning.

Authors:  Philipp Singer; Chuchu Zhang; Detlev Boison; Benjamin K Yee
Journal:  Pharmacol Biochem Behav       Date:  2013-01-02       Impact factor: 3.533

8.  Design, synthesis and biological evaluation of bivalent ligands against A(1)-D(1) receptor heteromers.

Authors:  Jian Shen; Lei Zhang; Wan-ling Song; Tao Meng; Xin Wang; Lin Chen; Lin-yin Feng; Ye-chun Xu; Jing-kang Shen
Journal:  Acta Pharmacol Sin       Date:  2013-01-21       Impact factor: 6.150

Review 9.  Disease-specific heteromerization of G-protein-coupled receptors that target drugs of abuse.

Authors:  Ivone Gomes; Wakako Fujita; Moraje V Chandrakala; Lakshmi A Devi
Journal:  Prog Mol Biol Transl Sci       Date:  2013       Impact factor: 3.622

10.  Adenosine A1-Dopamine D1 Receptor Heteromers Control the Excitability of the Spinal Motoneuron.

Authors:  Marla Rivera-Oliver; Estefanía Moreno; Yocasta Álvarez-Bagnarol; Christian Ayala-Santiago; Nicole Cruz-Reyes; Gian Carlo Molina-Castro; Stefan Clemens; Enric I Canela; Sergi Ferré; Vicent Casadó; Manuel Díaz-Ríos
Journal:  Mol Neurobiol       Date:  2018-05-24       Impact factor: 5.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.